Clinical Trial

Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 9, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis.
Trial Details
NCT Number NCT06196190
Lead Sponsor Rambam Health Care Campus
Conditions Cervix Cancer, HPV-Related Malignancy
Enrollment 200 participants
Start Date 2023-07-26
Primary Completion 2026-08-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-01-09